Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST

Trial Profile

Safety & Efficacy of a Combination Niacin ER/Simvastatin in Patients With Dyslipidemia: A Dose-Ranging Study - SEACOAST

Completed
Phase of Trial: Phase III

Latest Information Update: 15 May 2008

At a glance

  • Drugs Niacin/simvastatin; Simvastatin
  • Indications Hyperlipoproteinaemias; Lipid metabolism disorders
  • Focus Registrational; Therapeutic Use
  • Acronyms SEACOAST; SEACOAST-I; SEACOAST-II
  • Most Recent Events

    • 15 May 2008 Results of SEACOAST I published in American Journal of Cardiology.
    • 08 Aug 2006 Status change
    • 30 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top